METTL3 and coronary artery disorder: As shown in Figure 6A,B, m6A modification levels of RNA in monocytes from patients with CAD were significantly higher than those in healthy donors, and Mettl3 protein levels were markedly higher than those in healthy donors, which are consistent with our previous in‐vitro results (Figure 1A,C).